Is MDT's Neuroscience segment a long-term growth driver?

**Medtronic's Neuroscience segment is poised to be a long-term growth driver** for several reasons:

1. **Strong Recent Performance**: The Neuroscience segment has shown strong growth, with a 7.1% increase in revenue to $2.5 billion in Q2 2025. This growth is driven by strong organic growth across key sub-segments such as Neuromodulation, Cranial & Spinal Technologies, and Specialty Therapies.
2. **New Product Launches and Innovation**: Medtronic is actively innovating and launching new products in the Neuroscience segment, such as the Inceptiv™ spinal cord stimulator and Percept™ RC deep brain stimulator, which are contributing to growth. The company's focus on AI and digital solutions is also expected to enhance the value of its existing products and drive future growth.
3. **Market Capture and Strategic Focus**: Medtronic has strategically focused on capturing growth markets and has categorized its businesses based on three major growth markets, including Neurosurgery. This focus on high-growth areas is a positive indicator for long-term growth potential.
4. **Emerging Market Opportunities**: The company is seeing low-double-digit growth in emerging markets within the Neuroscience segment, which suggests that there is potential for continued growth as Medtronic expands its presence in these markets.
5. **Financial Outlook and Guidance**: Medtronic has raised its full-year revenue guidance to 4.75%-5% organic growth, which includes contributions from the Neuroscience segment. This guidance reflects confidence in the segment's ability to continue growing in the near term, which is a positive sign for long-term prospects.

In conclusion, the Neuroscience segment's strong performance, innovative product pipeline, strategic market focus, and positive financial outlook all point to its potential as a long-term growth driver for Medtronic.